Talk:Pemphigoid

Latest comment: 4 years ago by Iztwoz in topic Proposed split

Phemphigoid is another word for this disorder

edit

Could someone make it so that word redirects here when it's searched for?

http://www.entusa.com/oral_photos.htm http://www.eyesite.co.za/magazine/september2006/columns4.asp?mainbutton=columns&navbutton=columns4

These are examples showing it being used. You can tell they mean the same thing by the context. They must be two different ways of expressing the same thing. —Preceding unsigned comment added by Mizower (talkcontribs) 20:14, 15 June 2010 (UTC)Reply


Proposed split

edit

There was a 'Split' template posted in January but no place to discuss. Some items such as Bullous pemphigoid and Cicatricial pemphigoid were not linked; seems like there is a lot of duplicated info that could be merged if needed to the other entry pages.? Iztwoz (talk) 08:41, 21 July 2019 (UTC)Reply

agree--Ozzie10aaaa (talk) 04:35, 29 October 2019 (UTC)Reply
As per my path book, "Traditionally, this group of diseases has been classified into two main clinical subgroups; bullous pemphigoid, which usually involves skin but 30% of the time involves oral mucous membranes as well; and cictricial pemphigoid (mucous membrane pemphigoid), which involves mucous membranes (usually oral and /or conjunctival) and skin to a lesser extent (20%) and with less severity. Today, this group of diseases is categorized into two main clinical groups: cutaneous pemphigoid and mucosal phemphigoid. The mucosal phemphigoids are subclassified into three subgroups as follow: cicatricial, oral mucous membrane, and ocular." The entire section of the section is titled, "The pemphigoid group and other basement membrane autoimmue diseases" (pemphigoids being b cell-mediated) Ian Furst (talk) 01:25, 8 June 2020 (UTC)Reply
Bullous pemphigoid is still in common use. ? --Iztwoz (talk) 22:16, 9 June 2020 (UTC)[1]Reply

References

  1. ^ Kremer, N (April 2019). "Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature". American journal of clinical dermatology. 20 (2): 209–216. doi:10.1007/s40257-018-0401-6. PMID 30421306.